GABAergic interneuron transplants to study development and treat disease

Trends in Neurosciences

Volumn 37, Issue 3, 2014, Pages 169-177

  Tyson, Jennifer A ^a,b   Anderson, Stewart A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell based therapy; Cortical development; Fate determination; GABAergic interneurons; Neurological disease; Transplantation

Indexed keywords

ANXIETY; BRAIN CORTEX; CELL MIGRATION; CELL THERAPY; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; ENGRAFTMENT; FOREBRAIN; GABAERGIC SYSTEM; GAMMA AMINOBUTYRIC ACID INTERNEURON TRANSPLANT; HUMAN; INTERNEURON; MEDIAL GANGLIONIC EMINENCE TRANSPLANT; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PRECURSOR; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEIZURE; STEM CELL; TRANSPLANTATION;

CELL-BASED THERAPY; CORTICAL DEVELOPMENT; FATE DETERMINATION; GABAERGIC INTERNEURONS; NEUROLOGICAL DISEASE; TRANSPLANTATION;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL DIFFERENTIATION; GABAERGIC NEURONS; HUMANS; INTERNEURONS; NEURAL STEM CELLS; NEUROGENESIS; STEM CELL TRANSPLANTATION;

EID: 84894495428     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2014.01.003     Document Type: Review

References (81)

1. Tamamaki N., et al. Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse. J. Comp. Neurol. 2003, 467:60-79.
2. Marin O. Cellular and molecular mechanisms controlling the migration of neocortical interneurons. Eur. J. Neurosci. 2013, 38:2019-2029.
3. Tanaka D.H., Nakajima K. Migratory pathways of GABAergic interneurons when they enter the neocortex. Eur. J. Neurosci. 2012, 35:1655-1660.
4. Anderson S.A., et al. Distinct origins of neocortical projection neurons and interneurons in vivo. Cereb. Cortex 2002, 12:702-709.
5. Letinic K., et al. Origin of GABAergic neurons in the human neocortex. Nature 2002, 417:645-649.
6. Jones E.G. The origins of cortical interneurons: mouse versus monkey and human. Cereb. Cortex 2009, 19:1953-1956.
7. Yu X., Zecevic N. Dorsal radial glial cells have the potential to generate cortical interneurons in human but not in mouse brain. J. Neurosci. 2011, 31:2413-2420.
8. Hansen D.V., et al. Non-epithelial stem cells and cortical interneuron production in the human ganglionic eminences. Nat. Neurosci. 2013, 16:1576-1587.
9. Ma T., et al. Subcortical origins of human and monkey neocortical interneurons. Nat. Neurosci. 2013, 16:1588-1597.
10. Wichterle H., et al. Young neurons from medial ganglionic eminence disperse in adult and embryonic brain. Nat. Neurosci. 1999, 2:461-466.
11. Marin O., Rubenstein J.L. A long, remarkable journey: tangential migration in the telencephalon. Nat. Rev. Neurosci. 2001, 2:780-790.
12. Alvarez-Dolado M., et al. Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain. J. Neurosci. 2006, 26:7380-7389.
13. Wichterle H., et al. In utero fate mapping reveals distinct migratory pathways and fates of neurons born in the mammalian basal forebrain. Development 2001, 128:3759-3771.
14. Pla R., et al. Layer acquisition by cortical GABAergic interneurons is independent of Reelin signaling. J. Neurosci. 2006, 26:6924-6934.
15. Hevner R.F., et al. Postnatal shifts of interneuron position in the neocortex of normal and reeler mice: evidence for inward radial migration. Neuroscience 2004, 124:605-618.
16. Lodato S., et al. Excitatory projection neuron subtypes control the distribution of local inhibitory interneurons in the cerebral cortex. Neuron 2011, 69:763-779.
17. Flames N., et al. Delineation of multiple subpallial progenitor domains by the combinatorial expression of transcriptional codes. J. Neurosci. 2007, 27:9682-9695.
18. Inan M., et al. Spatial and temporal bias in the mitotic origins of somatostatin- and parvalbumin-expressing interneuron subgroups and the chandelier subtype in the medial ganglionic eminence. Cereb. Cortex 2012, 22:820-827.
19. Wonders C.P., et al. A spatial bias for the origins of interneuron subgroups within the medial ganglionic eminence. Dev. Biol. 2008, 314:127-136.
20. Taniguchi H., et al. The spatial and temporal origin of chandelier cells in mouse neocortex. Science 2013, 339:70-74.
21. DeFelipe J. Chandelier cells and epilepsy. Brain 1999, 122:1807-1822.
22. Woodruff A.R., et al. The enigmatic function of chandelier cells. Front. Neurosci. 2010, 4:201.
23. Lewis D.A., et al. Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci. 2012, 35:57-67.
24. Xu Q., et al. Sonic hedgehog signaling confers ventral telencephalic progenitors with distinct cortical interneuron fates. Neuron 2010, 65:328-340.
25. Du T., et al. NKX2.1 specifies cortical interneuron fate by activating Lhx6. Development 2008, 135:1559-1567.
26. Cobos I., et al. The vertebrate ortholog of Aristaless is regulated by Dlx genes in the developing forebrain. J. Comp. Neurol. 2005, 483:292-303.
27. Southwell D.G., et al. Intrinsically determined cell death of developing cortical interneurons. Nature 2012, 491:109-113.
28. Anderson S.A., et al. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 1995, 67:7-22.
29. Toyoizumi T., et al. A theory of the transition to critical period plasticity: inhibition selectively suppresses spontaneous activity. Neuron 2013, 80:51-63.
30. Fagiolini M., Hensch T.K. Inhibitory threshold for critical-period activation in primary visual cortex. Nature 2000, 404:183-186.
31. Southwell D.G., et al. Cortical plasticity induced by inhibitory neuron transplantation. Science 2010, 327:1145-1148.
32. Fagiolini M., et al. Specific GABAA circuits for visual cortical plasticity. Science 2004, 303:1681-1683.
33. Zipancic I., et al. Transplant of GABAergic precursors restores hippocampal inhibitory function in a mouse model of seizure susceptibility. Cell Transplant. 2010, 19:549-564.
34. Spencer S., Huh L. Outcomes of epilepsy surgery in adults and children. Lancet Neurol. 2008, 7:525-537.
35. Richardson R.M., et al. Developing cell transplantation for temporal lobe epilepsy. Neurosurg. Focus 2008, 24:E17.
36. Buzsaki G., et al. Suppression and induction of epileptic activity by neuronal grafts. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:9327-9330.
37. Lindvall O., Bjorklund A. Intracerebral grafting of inhibitory neurons. A new strategy for seizure suppression in the central nervous system. Adv. Neurol. 1992, 57:561-569.
38. Baraban S.C., et al. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15472-15477.
39. Calcagnotto M.E., et al. Grafting of GABAergic precursors rescues deficits in hippocampal inhibition. Epilepsia 2010, 51(Suppl. 3):66-70.
40. De la Cruz E., et al. Interneuron progenitors attenuate the power of acute focal ictal discharges. Neurotherapeutics 2011, 8:763-773.
41. Hunt R.F., et al. GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior. Nat. Neurosci. 2013, 16:692-697.
42. Shetty A.K., et al. Repair of the injured adult hippocampus through graft-mediated modulation of the plasticity of the dentate gyrus in a rat model of temporal lobe epilepsy. J. Neurosci. 2005, 25:8391-8401.
43. Shetty A.K., Hattiangady B. Restoration of calbindin after fetal hippocampal CA3 cell grafting into the injured hippocampus in a rat model of temporal lobe epilepsy. Hippocampus 2007, 17:943-956.
44. Shetty A.K. Progress in cell grafting therapy for temporal lobe epilepsy. Neurotherapeutics 2011, 8:721-735.
45. Naegele J.R., et al. Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy. Neuropharmacology 2010, 58:855-864.
46. de Munter J.P., et al. Cell based therapy in Parkinsonism. Transl. Neurodegener. 2013, 2:2-13.
47. Mallet N., et al. Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J. Neurosci. 2006, 26:3875-3884.
48. Kaplitt M.G., et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet 2007, 369:2097-2105.
49. Martinez-Cerdeno V., et al. Embryonic MGE precursor cells grafted into adult rat striatum integrate and ameliorate motor symptoms in 6-OHDA-lesioned rats. Cell Stem Cell 2010, 6:238-250.
50. Mann R., et al. Burden of spinal cord injury-related neuropathic pain in the United States: retrospective chart review and cross-sectional survey. Spinal Cord 2013, 51:564-570.
51. Eaton M.J., et al. Transplants of neuronal cells bioengineered to synthesize GABA alleviate chronic neuropathic pain. Cell Transplant. 1999, 8:87-101.
52. Braz J.M., et al. Forebrain GABAergic neuron precursors integrate into adult spinal cord and reduce injury-induced neuropathic pain. Neuron 2012, 74:663-675.
53. Daadi M.M., et al. Functional engraftment of the medial ganglionic eminence cells in experimental stroke model. Cell Transplant. 2009, 18:815-826.
54. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62:42-53.
55. Shen Q., et al. GABAergic control of critical developmental periods for anxiety- and depression-related behavior in mice. PLoS ONE 2012, 7:e47441.
56. Valente M.F., et al. Postnatal transplantation of interneuronal precursor cells decreases anxiety-like behavior in adult mice. Cell Transplant. 2013, 22:1237-1247.
57. Inan M., et al. Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia. Neurobiol. Dis. 2012, 53:36-48.
58. Korotkova T., et al. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68:557-569.
59. Tanaka D.H., et al. GABAergic precursor transplantation into the prefrontal cortex prevents phencyclidine-induced cognitive deficits. J. Neurosci. 2011, 31:14116-14125.
60. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int. J. Neuropsychopharmacol. 2004, 7(Suppl. 1):S1-S5.
61. Schobel S.A., et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 2013, 78:81-93.
62. Lisman J.E., et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008, 31:234-242.
63. Konradi C., et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr. Res. 2011, 131:165-173.
64. Lodge D.J. The MAM rodent model of schizophrenia. Curr. Protoc. Neurosci. 2013, 63. 9.43.1-9.43.7.
65. Perez S.M., Lodge D.J. Hippocampal interneuron transplants reverse aberrant dopamine system function and behavior in a rodent model of schizophrenia. Mol. Psychiatry 2013, 18:1193-1198.
66. Waldau B., et al. Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy. Stem Cells 2010, 28:1153-1164.
67. Watanabe K., et al. Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 2005, 8:288-296.
68. Maroof A.M., et al. Prospective isolation of cortical interneuron precursors from mouse embryonic stem cells. J. Neurosci. 2010, 30:4667-4675.
69. Danjo T., et al. Subregional specification of embryonic stem cell-derived ventral telencephalic tissues by timed and combinatory treatment with extrinsic signals. J. Neurosci. 2011, 31:1919-1933.
70. Maisano X., et al. Differentiation and functional incorporation of embryonic stem cell-derived GABAergic interneurons in the dentate gyrus of mice with temporal lobe epilepsy. J. Neurosci. 2012, 32:46-61.
71. Petros T.J., et al. Enhanced derivation of mouse ESC-derived cortical interneurons by expression of Nkx2.1. Stem Cell Res. 2013, 11:647-656.
72. Chen Y.J., et al. Use of 'MGE enhancers' for labeling and selection of embryonic stem cell-derived medial ganglionic eminence (MGE) progenitors and neurons. PLoS ONE 2013, 8:e61956.
73. Germain N.D., et al. Derivation and isolation of NKX2.1-positive basal forebrain progenitors from human embryonic stem cells. Stem Cells Dev. 2013, 22:1477-1489.
74. Goulburn A.L., et al. Generating GABAergic cerebral cortical interneurons from mouse and human embryonic stem cells. Stem Cell Res. 2012, 8:416-426.
75. Maroof A.M., et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell 2013, 12:559-572.
76. Liu Y., et al. Directed differentiation of forebrain GABA interneurons from human pluripotent stem cells. Nat. Protoc. 2013, 8:1670-1679.
77. Nicholas C.R., et al. Functional maturation of hPSC-derived forebrain interneurons requires an extended timeline and mimics human neural development. Cell Stem Cell 2013, 12:573-586.
78. Liu Y., et al. Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits. Nat. Biotechnol. 2013, 31:440-447.
79. Bortone D., Polleux F. KCC2 expression promotes the termination of cortical interneuron migration in a voltage-sensitive calcium-dependent manner. Neuron 2009, 62:53-71.
80. De Marco Garcia N.V., et al. Neuronal activity is required for the development of specific cortical interneuron subtypes. Nature 2011, 472:351-355.
81. Krook-Magnuson E., et al. On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy. Nat. Commun. 2013, 4:1376.